As With HIV, New York State Was Set to Lead the Nation to End Hepatitis C. But Why Haven’t the Recommendations Been Made Public?
Activist and member of the state task force Annette Gaudino would like the public to know.
This Week in HIV Research: PrEP Relief
Feb. 13, 2020: PrEP's psychosocial benefits; supplementing ADAP with Obamacare plans; lack of HIV and HCV testing for people who inject drugs; frailty is more common, but not more deadly, in HIV settings.
HIV Vaccine Trial Stopped Early, but Research Into Other Approaches Continues
HVTN 702 is but one of many vaccine trials underway, researchers note.
Want to Hire More Transgender and Gender Nonconforming Folks at Your Agency? These Staffers Have Some Blunt Advice
Many HIV service organizations say they’re open to hiring TGNC employees, but advocates say most have a long way to go.
Our Newest Posts
What's New in U.S. HIV Clinical Treatment Guidelines
We walk you through the most recent updates to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of people living with HIV.
New Study Will Test Safety of PrEP and Dapivirine Ring in Pregnancy
While the vaginal ring is still currently under FDA review, the new study will show whether it is safe and acceptable for people who are pregnant.
This Week in HIV Research: As Pill Burden Drops, Pill Cost Rises
Feb. 6, 2020: HIV medication costs outpace inflation; HIV's role in attenuating childhood vaccinations; the challenges of researching effects of medications during pregnancy; the need for localized HIV interventions in the U.S.
How to Develop a Curriculum Around HIV
Teaching young people of all ages about HIV is essential. But how do you start to outline a class?
Factors Associated With Hepatitis C Infection Among Men Who Take PrEP
IPERGAY scientists recommended that clinicians screen patients who request PrEP, as well as patients who are already using it, for a number of key HCV risk factors.
This Week in HIV Research: Our Attunement to Aging
Jan. 30, 2020: Polypharmacy vs. drug interaction risk among people living with HIV as they age; cost-effectiveness of ibalizumab; PrEP persistence on Medicaid vs. private health coverage.
Refer your clients and patients to TheBody, TheBodyPro's sibling site for people living with or affected by HIV. TheBody delivers vital information, news, support, and personal perspectives on HIV and related issues.
